- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Konica Minolta Launches New Handheld Ultrasound Device
Optimized for musculoskeletal assessment, needle guidance and vascular access, the PocketPro H2 wireless ultrasound unit reportedly provides 90 minutes of high-quality continuous scanning for point-of-care applications.
Combining ease of use features, strong compatibility with existing systems and robust image quality, Konica Minolta has launched the handheld, wireless ultrasound device PocketPro H2.
The ultrasound device reportedly facilitates rapid soft tissue assessment of ligaments, muscles, cartilage, inflammation, and joint instability, according to Konica Minolta. The company said clinicians can also employ the PocketPro H2 ultrasound for vascular access and needle guidance applications.
In addition to color and pulsed-wave Doppler capabilities and M-Mode functions, the PocketPro H2 offers an ergonomic design and customized imaging presets that promote ease of use.
The company noted a downloadable app allows wireless connection of the PocketPro H2 to the majority of iOS and Android smart devices and viewing of images at the point of care. Fully DICOM-compatible, the PocketPro H2 can also be linked to any PACS platform, according to Konica Minolta.
“Ultrasound has been called the new stethoscope of the 21st century and this advanced, wireless handheld unit helps clinicians do more with ultrasound at the point of care,” noted Joan Toth, a senior product marketing manager of ultrasound at Konica Minolta Healthcare.
(Editor’s note: For related content, see “Philips Set to Showcase Ultrasound Compact 5500CV at ASE Conference” and “New System Combines Diagnostic Ultrasound and Transient Elastography.”)
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
